Published in Obesity and Diabetes Week, July 3rd, 2006
"Adiponectin is an adipocyte-derived hormone that plays a critical role in the development of type 2 diabetes via interaction with adiponectin receptors 1 (ADIPOR1) and 2 (ADIPOR2). Rosiglitazone is a peroxisome proliferator-activated receptor-gamma (PPARG) agonist that is widely used in the treatment of type 2 diabetes. We hypothesized that rosiglitazone regulates lipid and glucose metabolism through modulation of the expression of adiponectin receptors in the liver," scientists in People's Republic of China report.
X. Sun and colleagues at the Chinese Academy of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week